Cognitive Telerehabilitation in Mild Cognitive Impairment, Alzheimer's Disease and Frontotemporal Dementia: A Systematic Review
Overview
Medical Informatics
Authors
Affiliations
Introduction: Given the limited effectiveness of pharmacological treatments, non-pharmacological interventions in neurodegenerative diseases have gained increasing attention in recent years and telerehabilitation has been proposed as a cognitive rehabilitation strategy. The purpose of this systematic review is to examine the evidence for the efficacy of cognitive telerehabilitation interventions compared with face-to-face rehabilitation in patients with mild cognitive impairment, Alzheimer's disease and frontotemporal dementia.
Methods: In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic search of the Medline database was conducted. Out of 14 articles assessed for eligibility, five studies were identified, three in participants with mild cognitive impairment or Alzheimer's disease, two in patients with primary progressive aphasia.
Results: The Physiotherapy Evidence Database scale was used to assess the methodological quality of four out of five studies included in this systematic review, with only one report receiving a high-quality rating. Effect-size analysis evidenced positive effects of telerehabilitation interventions, comparable with those reported for face-to-face rehabilitation.
Discussion: The available evidence for the effectiveness of cognitive telerehabilitation is limited, and the quality of the evidence needs to be improved. The systematic review provides preliminary evidence suggesting that cognitive telerehabilitation for neurodegenerative disease may have comparable effects as conventional in-person cognitive rehabilitation.
A systematic review of cognitive telerehabilitation in patients with cognitive dysfunction.
Jeon H, Kim D, Park S, Lee B, Han H, Jeon N Front Neurol. 2025; 15:1450977.
PMID: 39882355 PMC: 11774910. DOI: 10.3389/fneur.2024.1450977.
Manenti R, Baglio F, Pagnoni I, Gobbi E, Campana E, Alaimo C Front Aging Neurosci. 2024; 16:1414593.
PMID: 38966802 PMC: 11223647. DOI: 10.3389/fnagi.2024.1414593.
Suarez-Gonzalez A, Savage S, Alladi S, Amaral-Carvalho V, Arshad F, Camino J Int J Environ Res Public Health. 2024; 21(6).
PMID: 38929036 PMC: 11203756. DOI: 10.3390/ijerph21060790.
Peixoto C, Matioli M, Takano S, Teixeira M, Passos Neto C, Brucki S Arq Neuropsiquiatr. 2024; 82(4):1-9.
PMID: 38653483 PMC: 11039073. DOI: 10.1055/s-0044-1785690.
Darab M, Engel L, Henzler D, Lauerer M, Nagel E, Brown V Appl Health Econ Health Policy. 2024; 22(4):503-525.
PMID: 38554246 PMC: 11178626. DOI: 10.1007/s40258-024-00878-0.